- Home
- SYRA vs APM Comparison
SYRA vs APM Comparison
Compare SYRA & APM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SYRA
- APM
- Stock Information
- Founded
- SYRA 2020
- APM 2010
- Country
- SYRA United States
- APM United Kingdom
- Employees
- SYRA N/A
- APM N/A
- Industry
- SYRA Other Specialty Stores
- APM Biotechnology: Pharmaceutical Preparations
- Sector
- SYRA Industrials
- APM Health Care
- Exchange
- SYRA Nasdaq
- APM Nasdaq
- Market Cap
- SYRA 3.5M
- APM 4.0M
- IPO Year
- SYRA 2023
- APM 2018
- Fundamental
- Price
- SYRA $0.39
- APM $0.76
- Analyst Decision
- SYRA
- APM
- Analyst Count
- SYRA 0
- APM 0
- Target Price
- SYRA N/A
- APM N/A
- AVG Volume (30 Days)
- SYRA 247.7K
- APM 55.6K
- Earning Date
- SYRA 10-29-2024
- APM 12-27-2024
- Dividend Yield
- SYRA N/A
- APM N/A
- EPS Growth
- SYRA N/A
- APM N/A
- EPS
- SYRA N/A
- APM N/A
- Revenue
- SYRA $7,741,558.00
- APM $431,378.00
- Revenue This Year
- SYRA $47.74
- APM $157,729.10
- Revenue Next Year
- SYRA N/A
- APM N/A
- P/E Ratio
- SYRA N/A
- APM N/A
- Revenue Growth
- SYRA 35.47
- APM N/A
- 52 Week Low
- SYRA $0.34
- APM $0.46
- 52 Week High
- SYRA $8.37
- APM $17.49
- Technical
- Relative Strength Index (RSI)
- SYRA 44.58
- APM 40.52
- Support Level
- SYRA $0.36
- APM $0.73
- Resistance Level
- SYRA $0.43
- APM $0.78
- Average True Range (ATR)
- SYRA 0.04
- APM 0.09
- MACD
- SYRA -0.00
- APM 0.04
- Stochastic Oscillator
- SYRA 21.12
- APM 59.96
About SYRA Syra Health Corp.
Syra Health Corp is a healthcare services company promoting preventative health, holistic wellness, health education, and equitable healthcare for all patient demographics. The company leverages deep scientific and healthcare expertise to create strategic frameworks and develop patient-centric solutions for the betterment of patient lives and health outcome linked to developing a healthier population. It strives to offer comprehensive end-to-end solutions in health education services, population health management, behavioral and mental health, healthcare workforce and digital health.
About APM Aptorum Group Limited
Aptorum Group Ltd clinical-stage biopharmaceutical company. It is engaged in the discovery, development, and commercialization of therapeutic assets to treat diseases with unmet medical needs, particularly in oncology (including orphan oncology indications) and infectious diseases. The company operates in two segments: Therapeutics and Non-Therapeutics. The projects are ALS-4, SACT-1, and RPIDD. It is also engaged in providing healthcare services.